INS and Hypoglycemia: Basal insulin analogues such as insulin detemir were developed using recombinant techniques to provide a more physiological profile than human intermediate insulin preparations, and have been shown to be effective and safe in several randomized controlled trials, with a reduced risk of hypoglycaemia compared with traditional human insulins [22].